Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study.


Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2024
Historique:
received: 10 04 2024
accepted: 18 07 2024
medline: 2 9 2024
pubmed: 2 9 2024
entrez: 2 9 2024
Statut: epublish

Résumé

The prevalence of anxiety and depression in patients diagnosed with Alopecia Areata (AA) is very high and this significant burden of psychological symptoms threatens the Health-Related Quality of Life (HRQoL) of affected patients. Indeed, AA often does not produce significant physical symptoms, but it nonetheless disrupts many areas of mental health. Clinical assessment of disease severity may not reliably predict patient's HRQoL, nor may it predict the patient's perception of illness. For this reason, considerable effort has been made to apply and develop measures that consider patient's perception and assess the HRQoL of individuals affected by AA. The aim of this multicentric study was to provide the Italian version of the Skindex-16AA and to evaluate its psychometric properties in a clinical sample of consecutive patients with moderate-to-severe AA. This is a longitudinal, multicenter, observational study. Patients returned for follow-up visits at 4-, 12-, and 24-weeks. The analyses of the current work aimed to confirm the factorial structure of the Skindex-16AA. In the case of non-fit, an alternative structure for the model was proposed, using an Exploratory Graph Analysis and the Bayesian approach. The sample was composed of 106 patients with AA. Alopecia Universalis was the most frequently diagnosed type of alopecia at all time points. The analyses on the Skindex-16AA revealed that a two-factor structure with eight items fit the data best (Bayesian Posterior Predictive Checking using 95% Confidence Interval for the Difference Between the Observed and the Replicated Chi-Square values = -6.246/56.395, Posterior Predictive The Skindex-8AA demonstrated optimal psychometric properties (i.e., convergent and construct validity, and test-retest reliability) measured in a sample of patients with AA, that may suggest that it is an appropriate tool to measure the HRQoL in AA patients. However, further studies are needed in order to confirm and tested other psychometric features of this tool.

Identifiants

pubmed: 39220459
doi: 10.3389/fpubh.2024.1415334
pmc: PMC11363427
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1415334

Informations de copyright

Copyright © 2024 Caldarola, Raimondi, Samela, Pinto, Pampaloni, Starace, Diluvio, Dall'Oglio, Vagnozzi, de Felici del Giudice, Balestri, Ambrogio, Girolomoni, Riva, Moro, Atzori, Gallo, Ribero, Simonetti, Barruscotti, Boccaletti, Marzano, Bianchi, Micali, Piraccini, Fargnoli, Abeni and Peris.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Giacomo Caldarola (G)

UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy.
Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.

Giulia Raimondi (G)

Clinical Epidemiology Unit, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.

Tonia Samela (T)

Clinical Epidemiology Unit, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.
Clinical Psychology Unit, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.

Lorenzo Pinto (L)

UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy.
Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.

Francesca Pampaloni (F)

Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Department of Medical and Surgical Sciences University of Bologna, Bologna, Italy.

Michela Valeria Rita Starace (MVR)

Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Department of Medical and Surgical Sciences University of Bologna, Bologna, Italy.

Laura Diluvio (L)

Dermatology Unit, Fondazione Policlinico di Tor Vergata, Tor Vergata University of Rome, Rome, Italy.

Federica Dall'Oglio (F)

Dermatology Clinic, University of Catania, Catania, Italy.

Emanuele Vagnozzi (E)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Maria Beatrice de Felici Del Giudice (MB)

UOC Dermatologia, Dipartimento di Medicina e Chirurgia, Università di Parma, Parma, Italy.

Riccardo Balestri (R)

Division of Dermatology, "U.O. Multizonale APSS", Trento, Italy.

Francesca Ambrogio (F)

Section of Dermatology and Venereology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari "Aldo Moro", Bari, Italy.

Giampiero Girolomoni (G)

Dipartimento di Medicina, Sezione di Dermatologia, Università di Verona, Verona, Italy.

Silvia Francesca Riva (SF)

Department of Health Sciences (DISSAL), Section of Dermatology, University of Genoa, Genoa, Italy.
Department of Dermatology, Ospedale Policlinico San Martino IRCCS, Genoa, Italy.

Francesco Moro (F)

Dermatology Unit, IDI-IRCSS, Rome, Italy.

Laura Atzori (L)

Dermatology Unit, Department Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Giuseppe Gallo (G)

Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy.

Simone Ribero (S)

Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy.

Oriana Simonetti (O)

Clinica Dermatologica-Dipartimento di Scienze Cliniche e Molecolari Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Ancona, Italy.

Stefania Barruscotti (S)

Dermatology Clinic, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Department of Clinical-Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.

Valeria Boccaletti (V)

Clinica Dermatologica, Università degli Studi di Brescia, Brescia, Italy.

Angelo Valerio Marzano (AV)

Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.

Luca Bianchi (L)

Dermatology Unit, Fondazione Policlinico di Tor Vergata, Tor Vergata University of Rome, Rome, Italy.

Giuseppe Micali (G)

Dermatology Clinic, University of Catania, Catania, Italy.

Bianca Maria Piraccini (BM)

Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Department of Medical and Surgical Sciences University of Bologna, Bologna, Italy.

Maria Concetta Fargnoli (MC)

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Damiano Abeni (D)

Clinical Psychology Unit, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.

Ketty Peris (K)

UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy.
Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH